New research has revealed that people taking weight loss drugs like Wegovy and Mounjaro are increasingly more likely to ...

Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those with previous adverse reactions.

India's anti-obesity drug market is valued at Rs 3,000-3,500 crore and is projected to grow nearly eightfold to Rs 25,000 ...

A little weight gain during the menopause is normal, but when it happens to a generation who came of age in the skinny-chic ...

Paul Curran, MPharm, a clinical pharmacist with Optimal You in the UK, says there is one nasty side effect, in particular, ...

Mounjaro side effect explained as more than 220,000 Brits are expected to receive the drug over the next three years ...

Experts reveal how Mounjaro actually works on your body after people took to social media complaining over 'hair loss' side ...

Weight loss injections could be key to controlling a chronic condition in thousands of Brits, new research suggests ...

Several anti-obesity drugs, including Ozempic, Wegovy and Mounjaro, have created buzz in the Indian markets. But are they really approved for use in India? What are their side-effects? And how much do ...

Women who use an oral contraceptive might want to consider using a back-up method after starting a weight loss drug.

Patients who stop using weight loss medications are likely to return to their baseline weight within two years, a new analysis finds. Newer medications, such as Mounjaro and Wegovy, exhibit both ...

According to WebMD, Mounjaro can be classified similarly to Wegovy or Ozempic because all three all contain GLP-1, which assists in weight loss. Side effects can include nausea and diarrhea.